Pricing Log in Create free account

Monopar Therapeutics Inc. (MNPR) vs Ovid Therapeutics (OVID)

Monopar Therapeutics Inc. and Ovid Therapeutics are both Biotechnology companies. Monopar Therapeutics Inc. and Ovid Therapeutics are of similar size ($469.1M and $468.7M). Monopar Therapeutics Inc. has the higher net margin (0.00% vs −439.1%) and the higher return on invested capital (0.00% vs −35.1%). Across the 13 metrics below, Monopar Therapeutics Inc. leads on 11 and Ovid Therapeutics on 2.

Valuation

Metric MNPR OVID Biotechnology median
P/E n/m n/m 10.64
P/S n/m 60.33 9.59
P/B 4.55 2.26 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 46.84 9.45
Earnings yield (3.11%) (9.39%) (34.69%)
Free cash flow yield (2.05%) (11.59%) (24.02%)

Profitability

Metric MNPR OVID Biotechnology median
Gross margin — 100.00% 65.59%
Operating margin 0.00% (742.97%) 0.00%
Net margin 0.00% (439.11%) 0.00%
Free cash flow margin 0.00% (697.30%) 0.00%
Return on equity (19.50%) (25.97%) (51.96%)
Return on assets (18.90%) (22.30%) (46.06%)
Return on invested capital 0.00% (35.11%) 0.00%

Growth

Metric MNPR OVID Biotechnology median
Revenue growth (TTM) — 1,333.39% 4.59%
EPS growth (last fiscal year) 54.99% 37.84% 29.88%
Revenue growth, 5-year CAGR — (10.48%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MNPR OVID Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 33.56 12.39 4.86
Net debt to EBITDA 8.06 1.37 1.01

Dividend

Metric MNPR OVID Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric MNPR OVID Biotechnology median
Market cap 469.11m 468.71m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack